arrow
D

Daniel S.W. Tan

新加坡国立大学
H指数:55
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic and transcriptomic landscape of spread through air spaces in stage 1 lung adenocarcinoma

I期肺腺癌通过空气间隙扩散的基因组与转录组景观

2026-09-190
OAAI
AI-based augmentation of oncology clinical trials

基于人工智能的肿瘤学临床试验增强

2026-08-070
PRE
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial

纳武利尤单抗联合放化疗后序贯纳武利尤单抗联合或不联合伊匹木单抗治疗未经治疗的局部晚期Ⅲ期非小细胞肺癌:一项随机Ⅲ期试验

2026-05-130
OAAI
Corrigendum to ‘Lung Cancer Screening in Asia: An Expert Consensus Report’ [Journal of Thoracic Oncology Volume 18 Issue 10 (2023) 1303-1322]

《亚洲肺癌筛查:专家共识报告》勘误 [胸腺肿瘤学杂志 卷18 期10 (2023) 1303-1322]

2026-01-010
OA
Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer

诱导从葡萄糖代谢向酮体代谢的转变,是生酮饮食诱导的肺癌治疗易感性的编程机制。

2025-10-240
OAAI
Improving immune-related health outcomes post-cesarean birth with a gut microbiome-based program: A randomized controlled trial

通过基于肠道微生物组的方案改善剖宫产后的免疫相关健康结局:一项随机对照试验

2025-09-020
OAAI
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
2024-09-010
PRE
Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations
2024-04-082
OA